Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 700 of 3173 entries
View as:

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01155063 Org: User:
Start: 09/30/10 End: 09/30/11 Due: 09/30/12

A Multiple Dose Study Of PF-06678552 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02079922 Org: User:
Start: 03/31/14 End: 07/31/14 Due: 07/31/15

A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01612507 Org: User:
Start: 07/31/12 End: 11/30/12 Due: 11/30/13

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01309542 Org: User:
Start: 08/31/03 End: 03/31/06 Due: 03/31/07

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Phase: N/A Priority: Normal
NCT ID: NCT02687542 Org: User:
Start: 03/03/16 End: 11/10/17 Due: 11/10/18

Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT00150293 Org: User:
Start: 03/31/02 End: 11/30/05 Due: 11/30/06

Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT03309202 Org: User:
Start: 12/19/17 End: 07/18/18 Due: 07/18/19

A Study Testing A Radioactive Compound Given Through A Vein With And Without The Non-Radioactive Compound, Given By Mouth, To Characterize Tissue Distribution Using Positron Emission Tomography Scanning

Phase: N/A Priority: Normal
NCT ID: NCT02410525 Org: User:
Start: 05/31/15 End: 09/30/15 Due: 09/30/16

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00615056 Org: User:
Start: 03/31/08 End: 04/30/12 Due: 04/30/13

PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05233436 Org: User:
Start: 02/24/22 End: 10/16/23 Due: 10/16/24

Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01806896 Org: User:
Start: 09/30/13 End: 01/31/15 Due: 01/31/16

A Study To Asses Mass Balance And Absolute Bioavailability Of 14C PF-06826647 In Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04591262 Org: User:
Start: 11/10/20 End: 01/28/21 Due: 01/28/22

A Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Single Dose Vupanorsen In Healthy Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT04916795 Org: User:
Start: 06/17/21 End: 10/19/21 Due: 10/19/22

A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01469468 Org: User:
Start: 11/30/11 End: 12/31/11 Due: 12/31/12

A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02281552 Org: User:
Start: 11/18/14 End: 03/15/17 Due: 03/15/18

A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804

Phase: N/A Priority: Normal
NCT ID: NCT01924650 Org: User:
Start: 03/31/14 End: 06/30/14 Due: 06/30/15

A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03280173 Org: User:
Start: 09/29/17 End: 02/23/18 Due: 02/23/19

A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751

Phase: N/A Priority: Normal
NCT ID: NCT01981694 Org: User:
Start: 11/30/13 End: 02/28/14 Due: 02/28/15

A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01499004 Org: User:
Start: 11/30/11 End: 12/31/11 Due: 12/31/12

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT00275197 Org: User:
Start: 12/31/05 End: 07/31/07 Due: 07/31/08

A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.

Phase: N/A Priority: Normal
NCT ID: NCT03137134 Org: User:
Start: 06/20/17 End: 10/17/17 Due: 10/17/18

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Phase: N/A Priority: Normal
NCT ID: NCT03031938 Org: User:
Start: 11/03/17 End: 06/04/20 Due: 06/04/21

Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT02732938 Org: User:
Start: 05/04/16 End: 10/10/17 Due: 10/10/18

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04052204 Org: User:
Start: 12/30/19 End: 09/29/20 Due: 09/29/21

Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00338884 Org: User:
Start: 09/30/06 End: 04/30/09 Due: 04/30/10